Literature DB >> 30650026

Serum albumin level and long-term outcome in acute heart failure.

Arnaud Ancion1, Sophie Allepaerts2, Sébastien Robinet1, Cecile Oury1, Luc A Pierard1, Patrizio Lancellotti1,3.   

Abstract

Objective: Hypoalbuminemia is common in heart failure (HF), especially in elderly patients. It is associated with an increased risk of death. The present study sought to examine the prognostic significance of serum albumin level in the prediction of long-term mortality in patients admitted for acute HF.Methods and results: We examined the association between albumin and hospital mortality in a cohort of 509 patients admitted for acute HF. None of the patients had infectious disease, severe arrhythmias (atrial fibrillation, ventricular tachycardia, ventricular fibrillation), required invasive ventilation or presented with acute coronary syndrome or primary valvular disease. Sixty-nine patients (14%) died during the 1-year follow-up. With multivariable analysis, haemoglobin level (p = .003), systolic blood pressure (p = .004) and serum albumin level (p = .003) emerged as independent predictors of long-term mortality. Hypoalbuminemia (<35.7 g/L) had a hazard ratio of 2.01 (95% CI 1.24-3.25) and haemoglobin of 2.6 (95% CI 1.29-5.22) for predicting long-term mortality.Conclusions: Serum albumin level measured at admission, especially if combined with anaemia, can serve as a simple prognostic factor in acute HF for predicting long-term outcome.

Entities:  

Keywords:  Acute heart failure; albumin; long-term outcome

Mesh:

Substances:

Year:  2019        PMID: 30650026     DOI: 10.1080/00015385.2018.1521557

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  5 in total

Review 1.  Progress in bioactive surface coatings on biodegradable Mg alloys: A critical review towards clinical translation.

Authors:  Navdeep Singh; Uma Batra; Kamal Kumar; Neeraj Ahuja; Anil Mahapatro
Journal:  Bioact Mater       Date:  2022-05-15

2.  Short-Term Prognostic Efficacy of mGPS and LCS in Patients With Acute Heart Failure.

Authors:  Jing Wang; Ling Xie; Ping Lyu; Feng Zhou; Hong-Li Cai; Rong-Xing Qi; Qing Zhang
Journal:  Front Cardiovasc Med       Date:  2022-07-05

3.  In-Depth AGE and ALE Profiling of Human Albumin in Heart Failure: Ex Vivo Studies.

Authors:  Alessandra Altomare; Giovanna Baron; Marta Balbinot; Alessandro Pedretti; Beatrice Zoanni; Maura Brioschi; Piergiuseppe Agostoni; Marina Carini; Cristina Banfi; Giancarlo Aldini
Journal:  Antioxidants (Basel)       Date:  2021-02-27

4.  Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages.

Authors:  Takumi Hirata; Yasumichi Arai; Shinsuke Yuasa; Yukiko Abe; Michiyo Takayama; Takashi Sasaki; Akira Kunitomi; Hiroki Inagaki; Motoyoshi Endo; Jun Morinaga; Kimio Yoshimura; Tetsuo Adachi; Yuichi Oike; Toru Takebayashi; Hideyuki Okano; Nobuyoshi Hirose
Journal:  Nat Commun       Date:  2020-07-30       Impact factor: 14.919

5.  Population attributable risk estimates of risk factors for contrast-induced acute kidney injury following coronary angiography: a cohort study.

Authors:  Li Lei; Yan Xue; Zhaodong Guo; Bowen Liu; Yibo He; Feier Song; Jin Liu; Guoli Sun; Liling Chen; Kaihong Chen; Zhiqi Su; Li Pan; Zhidong Huang; Yulu Huang; Xiuqiong Huang; Shiqun Chen; Jiyan Chen; Yong Liu
Journal:  BMC Cardiovasc Disord       Date:  2020-06-12       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.